[1] |
安澜, 曾红梅, 冉显会, 等. 肝细胞癌和肝内胆管细胞癌流行病学研究进展[J]. 中国肿瘤, 2020(11): 879-884.
|
[2] |
格桑旺姆, 常中飞, 杜雅璐, 等. 2001—2017年我院原发性肝癌流行病学特征分析[J]. 中华介入放射学电子杂志, 2019, 7(3): 206-210.
|
[3] |
安天志, 高嵩, 靳勇, 等. 中国肝细胞癌经动脉化疗栓塞治疗(TACE)临床实践指南[J]. 介入放射学杂志, 2018(12): 1117-1126.
|
[4] |
闫东. 2018《CSCO原发性肝癌诊疗指南》解读——肝动脉介入治疗部分[J]. 肝癌电子杂志, 2018(3): 4-7.
|
[5] |
Lv N, Kong Y, Mu L, et al. Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma:a prospective randomized trial[J]. Eur Radiol, 2016, 26(10):3492-3499.
|
[6] |
王天成, 马聪, 肖煜东, 等. 利多卡因-表阿霉素-超液化碘油混合乳剂在肝癌TACE相关疼痛管理中的应用[J]. 介入放射学杂志, 2020(4): 366-371.
|
[7] |
Feng YL, Ling CQ, Zhai XF, et al. A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization[J]. J Altern Complement Med, 2009, 15(2): 175-181.
|
[8] |
Xu L, Wang S, Zhuang L, et al. Jian Pi Li Qi decoction alleviated postembolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a randomized, double-blind, placebo-controlled trial[J]. Integr Cancer Ther, 2016, 15(3): 349-357.
|
[9] |
Yang H, Seon J, Sung PS, et al. Dexamethasone prophylaxis to alleviate postembolization syndrome after transarterial chemoembolization for hepatocellular carcinoma: a randomized, double-blinded, placebo-controlled study[J]. J Vasc Interv Radiol, 2017, 28(11): 1503-1511.
|
[10] |
Guo JG, Zhao LP, Rao YF, et al. Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma[J]. Hepatobiliary & Pancreatic Diseases International, 2018, 17(6): 510-516.
|
[11] |
Lee SH, Hahn ST, Park SH. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration[J]. Cardiovasc Intervent Radiol, 2001, 24(6): 368-371.
|
[12] |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 传染病信息, 2020(6): 481-500.
|
[13] |
李麟荪, 徐阳, 林汉英. 介入护理学[G]. 北京: 人民卫生出版社, 2015.
|
[14] |
段甜, 孙晓芙, 韩月霞. 针对性护理对肝癌介入治疗患者胃肠道反应及疼痛的影响[J]. 临床医学工程, 2021, 28: 219-220.
|
[15] |
宋丽娜, 黄华, 袁萍. 多模式镇痛护理对肝动脉化疗栓塞术治疗肝癌患者负性情绪及疼痛的影响[J]. 当代护士(下旬刊), 2021, 28: 118-120.
|
[16] |
郑飞辉. 肝癌化疗栓塞术后疼痛的护理措施进展[J]. 医药前沿, 2021, 11: 190-191.
|
[17] |
首运凤, 李元涛. 利多卡因的临床作用及机制[J]. 中国临床新医学, 2021(5): 522-527.
|
[18] |
温雪敏, 宫云云, 范钦, 等. 利多卡因在围术期的研究进展及机制[J]. 麻醉安全与质控, 2021(2): 114-118.
|